CoChat

Experimental strategies to improve drug-target identification in mass spectrometry-based thermal stability assays

Phaneuf, Clifford G., Aizikov, Konstantin, Grinfeld, Dmitry, Kreutzmann, Arne, Mourad, Daniel, Lange, Oliver, Dai, Daniel, Zhang, Bailin, Belenky, Alexei, Makarov, Alexander A., Ivanov, Alexander R. · 2023 · Communications Chemistry
Cited by 15

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Mass spectrometry (MS)-based thermal stability assays have recently emerged as one of the most promising solutions for the identification of protein-ligand interactions. Here, we have investigated eight combinations of several recently introduced MS-based advancements, including the Phase-Constrained Spectral Deconvolution Method, Field Asymmetric Ion Mobility Spectrometry, and the implementation of a carrier sample as improved MS-based acquisition approaches for thermal stability assays (iMAATSA). We used intact Jurkat cells treated with a commercially available MEK inhibitor, followed by heat treatment, to prepare a set of unfractionated isobarically-labeled proof-of-concept samples to compare the performance of eight different iMAATSAs. Finally, the best-performing iMAATSA was compared to a conventional approach and evaluated in a fractionation experiment. Improvements of up to 82% and 86% were demonstrated in protein identifications and high-quality melting curves, respectively, over the conventional approach in the proof-of-concept study, while an approximately 12% improvement in melting curve comparisons was achieved in the fractionation experiment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42004-023-00861-1

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 28

  1. Seashore-Ludlow, B., Axelsson, H. & Lundbäck, T. Perspective on CETSA literature: toward more quantitative data interpretation. SLAS Discov.: Adv. Sci. Drug Discov. 25, 118–126 (2020). · DOI · Paper page
  2. Morgan, P. et al. Impact of a five-dimensional framework on R&D productivity at AstraZeneca. Nat. Rev. Drug Discov. 17, 167–181 (2018). · DOI · Paper page
  3. Bunnage, M. E. Getting pharmaceutical R&D back on target. Nat. Chem. Biol. 7, 335–339 (2011). · DOI · Paper page
  4. Friman, T., Chernobrovkin, A., Martinez Molina, D. & Arnold, L. CETSA MS profiling for a comparative assessment of FDA-approved antivirals repurposed for COVID-19 therapy identifies TRIP13 as a remdesivir off-target. SLAS Discovery: Adv. Life Sci. R. D. 26, 336–344 (2021). · DOI
  5. Molina, D. M. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84 (2013). · DOI · Paper page
  6. Grinfeld, D., Aizikov, K., Kreutzmann, A., Damoc, E. & Makarov, A. Phase-constrained spectrum deconvolution for fourier transform mass spectrometry. Anal. Chem. 89, 1202–1211 (2017). · DOI
  7. Kelstrup, C. D. et al. Limits for resolving isobaric tandem mass tag reporter ions using phase-constrained spectrum deconvolution. J. Proteome Res. 17, 4008–4016 (2018). · DOI · Paper page
  8. Gregus, M., Kostas, J. C., Ray, S., Abbatiello, S. E. & Ivanov, A. R. Improved sensitivity of ultralow flow LC-MS-based proteomic profiling of limited samples using monolithic capillary columns and FAIMS technology. Anal. Chem. 92, 14702–14712 (2020). · DOI
  9. Li, J., Van Vranken, J. G., Paulo, J. A., Huttlin, E. L. & Gygi, S. P. Selection of heating temperatures improves the sensitivity of the proteome integral solubility alteration assay. J. Proteome Res. 19, 2159–2166 (2020). · DOI · Paper page
  10. Yi, L. et al. Boosting to amplify signal with isobaric labeling (BASIL) strategy for comprehensive quantitative phosphoproteomic characterization of small populations of cells. Anal. Chem. 91, 5794–5801 (2019). · DOI · Paper page
  11. Peck Justice, S. A. et al. Boosting detection of low-abundance proteins in thermal proteome profiling experiments by addition of an isobaric trigger channel to TMT multiplexes. Anal. Chem. 93, 7000–7010 (2021). · DOI
  12. Sridharan, S. et al. Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP. Nat. Commun. 10, 1155 (2019). · DOI · Paper page
  13. Isshiki, Y. et al. Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent. Bioorg. Med. Chem. Lett. 21, 1795–1801 (2011). · DOI
  14. Franken, H. et al. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nat. Protoc. 10, 1567–1593 (2015). · DOI · Paper page
  15. Ishii, T. et al. CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens. Sci. Rep. 7, 1–14 (2017). · DOI · Paper page
  16. Martinez Molina, D. & Nordlund, P. The cellular thermal shift assay: a novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies. Annu. Rev. Pharmacol. Toxicol. 56, 141–161 (2016). · DOI · Paper page
  17. Reinhard, F. B. et al. Thermal proteome profiling monitors ligand interactions with cellular membrane proteins. Nat. Methods 12, 1129–1131 (2015). · DOI · Paper page
  18. Jarzab, A. et al. Meltome atlas—thermal proteome stability across the tree of life. Nat. Methods 17, 495–503 (2020). · DOI · Paper page
  19. Cheung, T. K. et al. Defining the carrier proteome limit for single-cell proteomics. Nat. Methods 18, 76–83 (2021). · DOI · Paper page
  20. Swearingen, K. E. et al. Nanospray FAIMS fractionation provides significant increases in proteome coverage of unfractionated complex protein digests. Mol. Cell Proteom. 11, M111 014985 (2012). · DOI
  21. Ohren, J. F. et al. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat. Struct. Mol. Biol. 11, 1192–1197 (2004). · DOI · Paper page
  22. Herneisen, A. L. et al. Identifying the target of an antiparasitic compound in toxoplasma using thermal proteome profiling. ACS Chem. Biol. 15, 1801–1807 (2020). · DOI
  23. Kawatkar, A. et al. CETSA beyond soluble targets: a broad application to multipass transmembrane proteins. ACS Chem. Biol. 14, 1913–1920 (2019). · DOI
  24. Hughes, C. S. et al. Ultrasensitive proteome analysis using paramagnetic bead technology. Mol. Syst. Biol. 10, 757 (2014). · DOI · Paper page
  25. Stopfer, L. E., Conage-Pough, J. E. & White, F. M. Quantitative consequences of protein carriers in immunopeptidomics and tyrosine phosphorylation MS(2) analyses. Mol. Cell Proteom. 20, 100104 (2021). · DOI
  26. Klann, K., Tascher, G. & Münch, C. J. M. C. Functional translatome proteomics reveal converging and dose-dependent regulation by mTORC1 and eIF2α. 77, 913–925.e914 (2020). · DOI · Paper page
  27. Lange, O., Damoc, E., Wieghaus, A. & Makarov, A. J. I. J. O. M. S. Reprint of “Enhanced Fourier transform for Orbitrap mass spectrometry”. 377, 338–344 (2015). · DOI
  28. Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442–D450 (2019). · DOI · Paper page

Cited by

See all 15

Metadata

Authors
Phaneuf, C. G., Aizikov, K., Grinfeld, D., Kreutzmann, A., Mourad, D., Lange, O., Dai, D., Zhang, B., Belenky, A., Makarov, A. A., & Ivanov, A. R.
Venue
Communications Chemistry
Published
2023-04-06
Volume
6
Issue
1
ISSN
2399-3669
Cited by
15
References
6
Language
en
Licence
Funders
U.S. Department of Health & Human Services | NIH | Center for Information Technology (R01CA218500, R35GM136421)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Experimental strategies to improve drug-target identification in mass spectrometry-based thermal stability assays. https://app.cochat.ai/papers/10.1038/s42004-023-00861-1
The paper
Phaneuf, C. G., Aizikov, K., Grinfeld, D., Kreutzmann, A., Mourad, D., Lange, O., Dai, D., Zhang, B., Belenky, A., Makarov, A. A., & Ivanov, A. R. (2023). Experimental strategies to improve drug-target identification in mass spectrometry-based thermal stability assays. Communications Chemistry. https://doi.org/10.1038/s42004-023-00861-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.